Not Signed In -
Creatinine |
|
|
Clinical Trial: Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients with Normal Creatinine Or Reduced Renal Function
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the renal perfusion depending on the MAP.
| Condition | Intervention |
|---|---|
| Kidney Failure, Acute | Procedure: controlling the MAP |
MedlinePlus related topics: Kidney Failure
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Uncontrolled, Crossover Assignment, Efficacy Study
Official Title: MAP and Renal Perfusion: Evaluation of Critically Ill Patients with Normal Creatinine Or Reduced Renal Function
Further Study Details:
Primary Outcomes: creatinine clearance after 4 hours
Secondary Outcomes: resistance index; diuresis; urinary indices of renal function
Expected Total Enrollment: 60
Secondary Outcomes: resistance index; diuresis; urinary indices of renal function
Expected Total Enrollment: 60
Study start: February 2003
Last follow-up: May 2005
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Over 18 years old
- Intensive care patient
- Treated with vasopressor
- Given informed consent
- Arterial infusion
- A bladder catheter
Exclusion Criteria:
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00117416
Eric Hoste, MD, PhD 0032/9/240.41.97 eric.hoste@UGent.be
Belgium
University Hospital Ghent, Ghent, 9000, Belgium; Recruiting
Eric Hoste, MD, PhD 0032/9/240.41.97 eric.hoste@UGent.be
Eric Hoste, MD, PhD, Principal Investigator
Eric Hoste, MD, PhD, Principal Investigator
Study chairs or principal investigators
Eric Hoste, MD, PhD, Principal Investigator, University Hospital Ghent
More Information
Study ID Numbers: 2002/382
Record last reviewed: May 2005
Last Updated: July 25, 2005
Record first received: July 6, 2005
ClinicalTrials.gov Identifier: NCT00117416
Health Authority: Belgium: Directorate general for the protection of Public health: Medicines
ClinicalTrials.gov processed this record on 2005-07-26
Record last reviewed: May 2005
Last Updated: July 25, 2005
Record first received: July 6, 2005
ClinicalTrials.gov Identifier: NCT00117416
Health Authority: Belgium: Directorate general for the protection of Public health: Medicines
ClinicalTrials.gov processed this record on 2005-07-26
email this page
print this page
bookmark this page
feedback on this page
